Cervical cell samples that are routinely collected as part of Pap smears may hold promise for predicting the risk of ovarian and other cancers, according to recent findings published as … Continued
The ovarian cancer community is counting on a hero… and that OCRA Hero could be you! If you’re looking to do good in 2022, it can be as simple (and … Continued
A prospective cohort study recently published on Vaccines set out to determine the safety and effectiveness of the Pfizer-BioNTech COVID-19 vaccine for gynecologic cancer patients undergoing chemotherapy treatment around the … Continued
Over the past decade, a new class of drugs called PARP inhibitors have been approved by the Food and Drug Administration (FDA) for use in ovarian cancer. Three FDA-approved PARP … Continued
Happy new year! While the temperatures may be chilly for many of us, we hope everyone is keeping warm with renewed hope for a year of progress toward our mission, … Continued
OCRA is pleased to announce the recipients of two research prizes, selected by members of our Scientific Advisory Committee for their notable contributions to the field of ovarian cancer research … Continued
It’s a new year, and there’s no better time to commit to simple actions that can make a big impact! So simple, that they take between one minute and half … Continued
New study findings not only reveal where the most common ovarian cancer subtype originates in certain patients, but also point to the future possibility of being able to predict who … Continued
Finding ways to minimize the pain caused by ovarian cancer can have a major impact on maximizing the quality of life for those dealing with this illness. Acupuncture is one … Continued
OCRA is pleased to announce the offering of an additional four groups to our Staying Connected online support group series. Staying Connected is facilitated by our Patient Support team and … Continued
Hereditary breast and ovarian cancer syndrome, known as HBOC, refers to a predisposition to develop cancer that is passed down through the generations of a family. HBOC is inherited in … Continued
More breakthroughs are on the horizon, as OCRA has awarded grants to 22 dedicated scientists at 15 prestigious medical institutions to enable future ovarian cancer discoveries. With this funding, OCRA … Continued
Get email updates about research news, action alerts, and ways to join the fight.
